• 2021

    1. Skotnicki M., Jadach B., Skotnicka A., Milanowski B., Tajber L., Pyda M., Kujawski J. Physicochemical characterization of co-amorphous atorvastatin-irbesartan system with a potential application in fixed-dose combination therapy. Pharmaceutics 13 (2021) 118. IF: 4.421
    2. Froelich A., Osmałek T., Jadach B., Puri V., Michniak-Kohn B. Microemulsion-based media in nose-to-brain drug delivery. Pharmaceutics 13 (2021) 201. IF: 4.421
    3. Wróblewska K.B., Plewa S., Długaszewska J., Froelich A., Muszalska-Kolos I. Design and evaluation of pharmaceutical availability, stability and quality of modified viscosity eye drops with choline salicylate. Eur. J. Pharm. Sci. 159 (2021) 105725. IF: 3.616
    4. Jakubowska E., Lulek J., The application of freeze-drying as a production method of drug nanocrystals and solid dispersions – A review, J. Drug Deliv. Sci. Technol. (2021): 62, art. 102357. IF: 2.734
    5. Hejduk A., Czajka S., Lulek J., Impact of co-processed excipient particles solidity and circularity on critical quality attributes of orodispersible minitablets, Powder Technol. 387 (2021) 494-508. IF: 4.142
    6. Czarczyńska-Goślińska B., Grześkowiak T., Frankowski R., Lulek J., Pieczak J., Zgoła-Grześkowiak A., Determination of bisphenols and parabens in breast milk and dietary risk assessment for Polish breastfed infants, J. Food Compost. Anal. 387 (2021) 1-10. IF: 3.721
    7. Lijewski S., Tydlitat J., Czarczyńska-Goślińska B., Klikar M., Mielcarek J., Gośliński T., Sobotta Ł., Synthesis and physico-chemical properties of [(1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy]-thiophen-5-yl)-substituted tetrapyrazinoporphyrazine with magnesium(II) ion, Appl. Sci. (Basel) 11 (2021) 1-12. IF: 2.474
    8. Cerbin-Koczorowska M., Waszyk-Nowaczyk M., Bakun P., Gośliński T., Koczorowski T., Current view on green tea catechins formulations, their interactions with selected drugs, and prospective applications for various health conditions., Appl. Sci. (Basel) 11 (2021) 4905. IF: 2.474